摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(tert-Butyl-dimethyl-silanyloxy)-9-methyl-benzo[de]chromen-3-one | 873425-79-7

中文名称
——
中文别名
——
英文名称
6-(tert-Butyl-dimethyl-silanyloxy)-9-methyl-benzo[de]chromen-3-one
英文别名
——
6-(tert-Butyl-dimethyl-silanyloxy)-9-methyl-benzo[de]chromen-3-one化学式
CAS
873425-79-7
化学式
C19H24O3Si
mdl
——
分子量
328.483
InChiKey
CRWVLQYZFCDZLV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.11
  • 重原子数:
    23.0
  • 可旋转键数:
    2.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    35.53
  • 氢给体数:
    0.0
  • 氢受体数:
    3.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-(tert-Butyl-dimethyl-silanyloxy)-9-methyl-benzo[de]chromen-3-one四丁基氟化铵 作用下, 以 四氢呋喃 为溶剂, 生成 8-Hydroxy-12-methyl-2-oxatricyclo[7.3.1.05,13]trideca-1(12),5(13),6,8,10-pentaen-4-one
    参考文献:
    名称:
    The structure–activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs
    摘要:
    For the systematic SAR study on mansonone F, a series of C6 and C9 analogs of mansonone F have been synthesized and their anti-MRSA activities were evaluated. Most of the analogs exhibited good or excellent anti-MRSA activities. In particular, the 6-n-butylmansonone F showed fourfold higher antibacterial activities compared to that of vancomycin. (c) 2005 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2005.09.024
  • 作为产物:
    描述:
    参考文献:
    名称:
    The structure–activity relationships of mansonone F, a potent anti-MRSA sesquiterpenoid quinone: SAR studies on the C6 and C9 analogs
    摘要:
    For the systematic SAR study on mansonone F, a series of C6 and C9 analogs of mansonone F have been synthesized and their anti-MRSA activities were evaluated. Most of the analogs exhibited good or excellent anti-MRSA activities. In particular, the 6-n-butylmansonone F showed fourfold higher antibacterial activities compared to that of vancomycin. (c) 2005 Published by Elsevier Ltd.
    DOI:
    10.1016/j.bmcl.2005.09.024
点击查看最新优质反应信息